CompletedNANCT05022589

Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk

Sponsor: Posit Science Corporation

Trial Details

ConditionFall
InterventionComputerized Plasticity-Based Adaptive Cognitive Training
PhaseNA
StatusCompleted
Participants32
Est. Completion19 Apr 2024
Last Updated10 June 2026

Primary Outcome

Net Promoter Score (NPS)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Participants who are 65 years of age or older. 2. Participants must be US residents. 3. Participant with at least one self-reported fall within the last 1 year or difficulty walking one half a mile or difficulty climbing one flight of stairs. 4. Participants who are fluent English speakers from the age of 12, per self-report, to ensure reasonable neuropsychological results on key assessments. 5. Participant must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse or a tablet. Exclusion Criteria: 1. Participants had joint replacement surgery or significant join/leg injury less than one year prior to the screening visit. 2. Participants have a joint replacement surgery scheduled within the next 6 months. 3. Participants use a walker or wheelchair on a regular basis. 4. Participants have a diagnosis of benign paroxysmal positional vertigo (BPPV), labyrinthitis or suffers migraines that result in chronic vertigo. 5. Participants self-reports vision or hearing difficulties that would interfere with the ability to complete the study tasks. 6. Participants with untreated psychiatric conditions, including substance abuse/dependence disorders, recent hospitalization, ongoing chemotherapy or other cancer treatment. 7. Participants with medical illnesses, injuries or conditions predisposing to imminent functional and/or cognitive decline (e.g. multiple sclerosis, stroke, traumatic brain injury, dementia, etc.) 8. Participants enrolled in a concurrent clinical trial involving an intervention targeting physical functioning to prevent falls; investigational pharmaceutical; nutraceutical; medical device; or behavioral treatment that could affect the outcome of this study. However, participation in standard treatments (e.g., occupational therapy) or use of prescribed medications (e.g., anti-depressants) is allowable. 9. Participants using computer-based cognitive training programs or has used it within a month of the consent date. 10. Participants who answered 'yes' to questions 4 (Active Suicidal Ideation with Intent) or 5 (Active Suicidal Ideation with Specific Plan and Intent) on the Columbia-Suicide Severity Rating Scale (C-SSRS) or 'yes' to any of the suicide-related behaviors (actual attempt, interrupted attempt, aborted attempt, preparatory act or behavior) on the C-SSRS "Suicidal Behavior" if the ideation or behavior occurred within 2 months from Participant's date of consent.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service